A61K 31/5377, A61K 9/5153, A61K 9/5192
A novel nanoparticle drug composition and method of use thereof is presented herein. The nanoparticle drug composition is comprised of at least one nanoparticle carrier, formed from the conjugation of PLGA and PEG, which encapsulates a drug such as afobazole and its derivatives, in a pharmaceutically acceptable carrier. The nanoparticle drug composition may be used to treat various diseases of the central nervous system involving excessive neuronal activity and inflammation such as stroke, Alzheimer's disease and anxiety.
Cuevas, Javier; Katnik, Christopher; and Sutariya, Vijaykumar B., "Afobazole nanoparticles formulation for enhanced therapeutics" (2019). USF Patents. 969.
University of South Florida